Mimedx Group, Inc. 

GA

  SEC # 1376339

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  9/26/06   —   First EDGAR Filing:  3/6/07   –   Last Filing:  4/24/24 

Business Address      On:  4/24/24       [ Map ]		Mailing Address      On:  4/24/24       [ Map ]
1775 W Oak Commons Court, Ne Marietta, Georgia  30062 U.S.A.

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 770-651-9100		Florida, U.S.A.		12/31/yy		26-2792552		0001376339		001-35887

Market: Symbol:  Nasdaq: MDXG

— Common Stock

In Major Indexes:	S&P Total Market — NASDAQ Composite — Russell 2000  &  Russell 3000  and  Russell Microcap

Industry Classification

GICS – Global Industry Classification Standard:        Sector      →    Sub-Industry   Health Care Biotechnology   ICB – Industry Classification Benchmark:               Industry    →       Subsector      Health Care Biotechnology   SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 3841 Surgical and Medical Instruments and Apparatus 2024 SEC Office of Industrial Applications & Services 6770 Special-Purpose Acquisition Companies (SPACs), a.k.a. Blank Checks, et al. 2008 SEC Office of Real Estate & Construction

        

Management
Director   In   TX   Olson Tiffany 2024   MA   Puhy Dorothy E 2024   CA   Behrens M Kathleen 2019-2023   VA   Bierman James L 2019-2023   TX   Newton Todd 2019-2023   GA   Giuliani Michael J 2020-2023   MN   Hawkins William A 2020-2023   CT   Laurencin Cato T 2020-2023   CA   Gardner Phyllis 2021-2023   NC   Wright Timothy R 2020-2022   NY   Koob Charles E 2008-2020   GA   Dewberry J Terry 2009-2020   TN   Evans Charles Robert 2012-2020   GA   Yeston Neil 2012-2020   CA   Barry Richard 2019-2020   TX   Sutter Martin P 2020 ↓List Pre-2020 Directors				Officer  Since  Most-Recent Title   In   TX   Doug Rice 2023 Chief Financial Officer 2024   NJ   Whitlow Ricci S 2023 Chief Operating Officer 2024   GA   Hulse William Frank IV 2019 General Counsel & CAO 2024   PA   Capper Joseph H Chief Executive Officer 2023   GA   Phelan William Lawrence 2020 Chief Accounting Officer 2023   MA   Stein Robert Benjamin 2020 President, Regenerative Med. 2023   NC   Carlson Peter M 2019 Chief Financial Officer 2023   TX   Newton Todd Interim CEO 2022   GA   Graves Mark 2020 SVP & Chief Compliance Officer 2022   TX   Kashyap Rohit 2020 President, WC & Surgical 2022   NC   Wright Timothy R 2019 Chief Executive Officer 2022   GA   Turner Scott M 2018 SVP, Operations & Procurement 2022 ↓List Pre-2020 Officers

        

        

        

        

Securities
Market:  Symbol    Description        (Prices) (Type — Name)   Nasdaq:  MDXG   Common Stock — COM USD.001 _________  Symbol source:  SEC  As of:  4/25/24		CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2024:   602496 602496·10·1     Common — COM USD.001 ← MDXG 602496·01·0     Options _________  Classes source:  Form 13F Filings that list Section 13(f) Securities